Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 3, 2007, Pages 991-997

  Humphreys, G S ^a   Merinopoulos, I ^a   Ahmed, J ^a   Whitty, C J M ^a   Mutabingwa, T K ^a,b   Sutherland, C J ^a   Hallett, R L ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; FANSIDAR; MOLECULAR MARKER; MULTIDRUG RESISTANCE PROTEIN 1;

AFRICA; ALLELE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FOLLOW UP; GENE; GENOTYPE; HAPLOTYPE; HOST SELECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; MONOTHERAPY; PFMDR1 GENE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TANZANIA; TREATMENT FAILURE; TREATMENT RESPONSE;

ALLELES; AMODIAQUINE; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; DRUG RESISTANCE; ETHANOLAMINES; FEMALE; FLUORENES; GENOTYPE; HAPLOTYPES; HUMANS; INFANT; LINKAGE (GENETICS); MALARIA, FALCIPARUM; MALE; P-GLYCOPROTEIN; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; TANZANIA; TREATMENT OUTCOME;

EID: 33847655633     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00875-06     Document Type: Article

References (31)

1. Djimde, A., O. K. Doumbo, J. F. Cortese, K. Kayentao, S. Doumbo, Y. Diourte, A. Dicko, X. Z. Su, T. Nomura, D. A. Fidock, T. E. Wellems, C. V. Plowe, and D. Coulibaly. 2001. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344:257-263.
2. Dokomajilar, C., S. L. Nsobya, B. Greenhouse, P. J. Rosenthal, and G. Dorsey. 2006. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob. Agents Chemother. 50:1893-1895.
3. Reference deleted.
4. Duraisingh, M. T., P. Jones, I. Sambou, L. von Seidlein, M. Pinder, and D. C. Warhurst. 2000. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol. Biochem. Parasitol. 108:13-23.
5. Famin, O., and H. Ginsburg. 2002. Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes. Biochem. Pharmacol. 63:393-398.
6. Hallett, R. L., C. J. Sutherland, N. Alexander, R. Ord, M. Jawara, C. J. Drakeley, M. Pinder, G. Walraven, G. A. T. Targett, and A. Alloueche. 2004. Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes. Antimicrob. Agents Chemother. 48:3940-3943.
7. Hayward, R., K. J. Saliba, and K. Kirk. 2005. Pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Mol. Microbiol. 55:1285-1295.
8. Holmgren, G., J. P. Gil, P. M. Ferreira, M. I. Veiga, C. O. Obonyo, and A. Björkman. 2006. Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect. Genet. Evol. 6:309-314.
9. Meerman, L., R. Ord, J. T. Bousema, M. van Niekerk, E. Osman, R. Hallett, M. Pinder, G. Walraven, and C. J. Sutherland. 2005. Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children. J. Infect. Dis. 192:1651- 1657.
10. Mutabingwa, T. K., D. Anthony, A. Heller, R. Hallett, J. Ahmed, C. Drakeley, B. M. Greenwood, and C. J. M. Whitty. 2005. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet 365:1474- 1480.
11. Ochong, E. O., I. V. van den Broek, K. Keus, and A. Nzila. 2003. Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. Am. J. Trop. Med. Hyg. 69:184-187.
12. Olliaro, P., and P. Mussano. 2003. Amodiaquine for treating malaria. Cochrane Database Syst. Rev. 2:CD000016.
13. Olliaro, P. L., and W. R. Taylor. 2004. Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: a review. J. Postgrad. Med. 50:40-44.
14. Pearce, R. J., C. Drakeley, D. Chandramohan, F. Mosha, and C. Roper. 2003. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob. Agents Chemother. 47:1347-1354.
15. Pickard, A. L., C. Wongsrichanalai, A. Purfield, D. Kamwendo, K. Emery, C. Zalewski, F. Kawamoto, R. Scott Miller, and S. R. Meshnick. 2003. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob. Agents Chemother. 47:2418-2423.
16. Plowe, C. V., A. Djimde, M. Bouare, O. Doumbo, and T. E. Wellems. 1995. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am. J. Trop. Med. Hyg. 52:565-568.
17. Price, R., J. A. Simpson, P. Teja-Isavatharm, M. M. Than, C. Luxemburger, D. G. Heppner, T. Chongsuphajaisiddhi, F. Nosten, and N. J. White. 1999. Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria. Antimicrob. Agents Chemother. 43:341-346.
18. Price, R. N., C. Cassar, A. Brockman, M. Duraisingh, M. van Vugt, N. J. White, F. Nosten, and S. Krishna. 1999. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother. 43:2943-2949.
19. Price, R. N., A. C. Uhlemann, A. Brockman, R. McGready, E. Ashley, L. Phaipun, R. Patel, K. Laing, S. Looareesuwan, N. J. White, F. Nosten, and S. Krishna. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364:438-447.
20. Price, R. N., A.-C. Uhlemann, M. van Vugt, A. Brockman, R. Hutagalung, S. Nair, D. Nash, P. Singhasivanon, T. J. C. Anderson, S. Krishna, N. J. White, and F. Nosten. 2006. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin. Infect. Dis. 42:1570-1577.
21. Reed, M. B., K. J. Saliba, S. R. Caruana, K. Kirk, and A. F. Cowman. 2000. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403:906-909.
22. Roper, C., R. Pearce, S. Nair, B. Sharp, F. Nosten, and T. Anderson. 2004. Intercontinental spread of pyrimethamine-resistant malaria. Science 305:1124.
23. Sidhu, A. B., D. Verdier-Pinard, and D. A. Fidock. 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298:210-213.
24. Sidhu, A. B., S. G. Valderramos, and D. A. Fidock. 2005. Pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol. Microbiol. 57:913-926.
25. Sisowath, C., J. Strömberg, A. Mårtensson, M. Msellem, C. Obondo, A. Björkman, and J. P. Gil. 2005. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether- lumefantrine (Coartem). J. Infect. Dis. 191:1014-1017.
26. Snounou, G., X. Zhu, N. Siripoon, W. Jarra, S. Thaithong, K. N. Brown, and S. Viriyakosol. 1999. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans. R. Soc. Trop. Med. Hyg. 93:369-374.
27. Sutherland, C. J., C. J. Drakeley, U. Obisike, R. Coleman, M. Jawara, G. A. T. Targett, P. Milligan, M. Pinder, and G. Walraven. 2003. The addition of artesunate to chloroquine for the treatment of Plasmodium falciparum malaria in Gambian children delays, but does not prevent treatment failure. Am. J. Trop. Med. Hyg. 69:19-25.
28. Sutherland, C. J., R. Ord, S. Dunyo, M. Jawara, C. J. Drakeley, N. Alexander, R. Coleman, M. Pinder, G. Walraven, and G. A. T. Targett. 2005. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artememether. PLoS Med. 2:e92.
29. Warhurst, D. C. 2003. Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine. Malaria J. 2:31.
30. White, N. 1999. Antimalarial drug resistance and combination chemotherapy. Philos. Trans. R. Soc. Lond. B. 354:739-749.
31. World Health Organization. 2001. Antimalarial drug combination therapy: report of a WHO technical consultation. WHO, Geneva, Switzerland. www.rbm.who.int/cmc_upload/0/000/015/082/use_of_antimalarials2.